Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Total Current Liabilities: 2015-2024

Historic Total Current Liabilities for Sunshine Biopharma (SBFM) over the last 10 years, with Dec 2024 value amounting to $6.3 million.

  • Sunshine Biopharma's Total Current Liabilities rose 46.88% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 46.88%. This contributed to the annual value of $6.3 million for FY2024, which is 13.74% up from last year.
  • As of FY2024, Sunshine Biopharma's Total Current Liabilities stood at $6.3 million, which was up 13.74% from $5.6 million recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Total Current Liabilities peaked at $6.9 million during FY2022, and registered a low of $91,229 during FY2021.
  • Moreover, its 3-year median value for Total Current Liabilities was $6.3 million (2024), whereas its average is $6.3 million.
  • In the last 5 years, Sunshine Biopharma's Total Current Liabilities slumped by 91.32% in 2021 and then spiked by 7,497.38% in 2022.
  • Over the past 5 years, Sunshine Biopharma's Total Current Liabilities (Yearly) stood at $1.1 million in 2020, then crashed by 91.32% to $91,229 in 2021, then surged by 7,497.38% to $6.9 million in 2022, then decreased by 19.90% to $5.6 million in 2023, then increased by 13.74% to $6.3 million in 2024.